Novel approaches to reduce temozolomide resistance in glioblastoma multiforme: a review of the literature
Temozolomide (TMZ), an oral alkylating agent, is currently used as a part of standard treatment for glioblastoma multiforme (GBM). GBM is considered one of the most lethal forms of human cancers, and despite recent improvement in cancer therapy, it remains an incurable disease, with a rare long-term...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Verduci Editore
2019-11-01
|
| Series: | World Cancer Research Journal |
| Subjects: | |
| Online Access: | https://www.wcrj.net/wp-content/uploads/sites/5/2019/11/e1431-Novel-approaches-to-reduce-temozolomide-resistance-in-glioblastoma-multiforme-a-review-of-the-literature.pdf |